Why the study?
Statins prevent ASCVD, but widespread underuse persists across practice settings and populations, prompting investigation into whether cardiologist intervention improves guideline-directed statin therapy implementation.
Does cardiologist co-management improve adherence to guideline-directed statin therapy compared to general internists alone in the ambulatory setting?
Does cardiologist co-management improve adherence to guideline-directed statin therapy compared to general internists alone in the ambulatory setting?
Cardiologist co-management does not significantly improve adherence to guideline-directed statin therapy compared to general internist management alone, highlighting a universal need for better implementation strategies.
BACKGROUND: Statins have an important and well-established role in the prevention of atherosclerotic cardiovascular disease (ASCVD). However, several studies have reported widespread underuse of statins in various practice settings and populations. Review of relevant literature reveals opportunities for improvement in the implementation of guideline-directed statin therapy (GDST). AIM: To examine the impact of cardiologist intervention on the use of GDST in the ambulatory setting. Analysis of Variance was used to compare rates of adherence to GDST. RESULTS: < 0.02, all). CONCLUSION: Although overall use of GDST was suboptimal, there was no statistical difference in appropriate statin use based on guidelines between groups managed by general internists alone or co-managed with a cardiologist. These findings highlight the need to design and implement strategies to improve adherence rates to GDST across all specialties.
No takes yet. Share an insight, caveat, or question.
Cassagnol et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: